3 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Pentosan polysulfate sodium: new trials by email Literature Review of Pentosan polysulfate sodium trials Research Report on Pentosan polysulfate sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders Meclofenamic acid, Pentosan polysulfate sodium - Psychotic Disorders, Schizophrenia | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 8 | 2015-08-07 | 2019-03-26 |
| Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy pentosan polysulfate sodium, quality-of-life assessment - Diarrhea, Radiation Enteritis | Phase 3 | Completed | Radiation Therapy Oncology Group | 174 | 1999-06-01 | 2020-10-19 |
| An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland pentosan polysulfate sodium - Prostatitis | Phase 2 | Completed | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | 283 | 2011-07-01 |
Bipolar Disorder (1) · Diarrhea (1) · Mental Disorders (1) · Prostatitis (1) · Psychotic Disorders (1) · Schizophrenia (1)
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. (1) · Radiation Therapy Oncology Group (1) · The University of Texas Health Science Center, Houston (1)
United States (2) · Canada (1)